These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23969591)

  • 1. National antiviral treatment program and the incidence of hepatocellular carcinoma and associated mortality in Taiwan: a preliminary report.
    Chang CH; Lin JW; Wu LC; Liu CH; Lai MS
    Med Care; 2013 Oct; 51(10):908-13. PubMed ID: 23969591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of hepatocellular carcinoma in ESRD patients: caused by high hepatitis rate or 'uremia'? a population-based study.
    Hwang JC; Weng SF; Weng RH
    Jpn J Clin Oncol; 2012 Sep; 42(9):780-6. PubMed ID: 22782961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant reduction in end-stage liver diseases burden through the national viral hepatitis therapy program in Taiwan.
    Chiang CJ; Yang YW; Chen JD; You SL; Yang HI; Lee MH; Lai MS; Chen CJ
    Hepatology; 2015 Apr; 61(4):1154-62. PubMed ID: 25476749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.
    Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC
    Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hospital- and community-based screenings for hepatocellular carcinoma in Taiwan.
    Kee KM; Lu SN
    Oncology; 2011; 81 Suppl 1():36-40. PubMed ID: 22212934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.
    Chang MH; Chen CJ; Lai MS; Hsu HM; Wu TC; Kong MS; Liang DC; Shau WY; Chen DS
    N Engl J Med; 1997 Jun; 336(26):1855-9. PubMed ID: 9197213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan.
    Liao SH; Chen CL; Hsu CY; Chien KL; Kao JH; Chen PJ; Chen TH; Chen CH
    J Hepatol; 2021 Jul; 75(1):132-141. PubMed ID: 33689789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
    Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
    Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
    Chang MH; You SL; Chen CJ; Liu CJ; Lee CM; Lin SM; Chu HC; Wu TC; Yang SS; Kuo HS; Chen DS;
    J Natl Cancer Inst; 2009 Oct; 101(19):1348-55. PubMed ID: 19759364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical evaluation of the preventive effect of antiviral therapy on the development of hepatocellular carcinoma in patients with chronic hepatitis C or B: a novel approach by using meta-regression.
    Shen YC; Hsu C; Cheng CC; Hu FC; Cheng AL
    Oncology; 2012; 82(5):275-89. PubMed ID: 22555181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.
    Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
    J Gastroenterol; 2005 Feb; 40(2):148-56. PubMed ID: 15770398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the incidence of hepatocellular carcinoma in boys and girls in Taiwan after large-scale hepatitis B vaccination.
    Lee CL; Hsieh KS; Ko YC
    Cancer Epidemiol Biomarkers Prev; 2003 Jan; 12(1):57-9. PubMed ID: 12540504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
    Wang CS; Yao WJ; Chang TT; Wang ST; Chou P
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatectomy for hepatitis B-, hepatitis C-, and dual hepatitis B- and C-related hepatocellular carcinoma in Taiwan.
    Lee WC; Jeng LB; Chen MF
    J Hepatobiliary Pancreat Surg; 2000; 7(3):265-9. PubMed ID: 10982625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
    Lai MS; Hsieh MS; Chiu YH; Chen TH
    Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
    Thein HH; Walter SR; Gidding HF; Amin J; Law MG; George J; Dore GJ
    J Viral Hepat; 2011 Jul; 18(7):e232-41. PubMed ID: 21692938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
    Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.